ROLE OF HUMAN SYMBIOTIC FLORA IN IMPROVING TUMOR IMMUNOTHERAPY RESPONSE

Title:

ROLE OF HUMAN SYMBIOTIC FLORA IN IMPROVING TUMOR IMMUNOTHERAPY RESPONSE

Document Type and Number:

WIPO Patent Application WO/2021/175339

Kind Code:

A1

Abstract:

The present disclosure relates to a bacterial liquid of healthy human intestinal flora, and a method for preparation thereof and quality control thereof. The present disclosure also relates to a combination of a bacterial solution of healthy human intestinal flora and an immune signal path regulator, used for treating cancer patients to improve tumor response to immunotherapy.

More Like This:

WO/2023/072186	COMPOSITIONS AND METHODS FOR ENHANCING EFFICACY AND REDUCING ADVERSE EFFECTS FROM COVID VACCINATION
JP7104435	Biological microorganism-containing composition and method for producing the same
WO/2017/147507	SKIN PROBIOTIC FORMULATION

Inventors:

YIN YIMING (CN)
TAN YAN (CN)
LIU DING (CN)
ZHANG CONG (CN)
GAO TING (CN)

Application Number:

PCT/CN2021/087593

Publication Date:

September 10, 2021

Filing Date:

April 15, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SHENZHEN XBIOME BIOTECH CO LTD (CN)

International Classes:

A61K35/741; A61P35/00; C12N15/11

Domestic Patent References:

WO2018071534A1

2018-04-19

Foreign References:

CN111249314A	2020-06-09
CN110582291A	2019-12-17
CN107513515A	2017-12-26

Attorney, Agent or Firm:

MERITS & TREE (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: PSMA COMBINER AND USE THEREOF

Next Patent: LEVELING CONTROL METHOD, APPARATUS, AND SYSTEM, AND MOTOR GRADER